000 01486 a2200421 4500
005 20250513190340.0
264 0 _c19990902
008 199909s 0 0 eng d
022 _a0190-9622
024 7 _a10.1016/s0190-9622(99)70051-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDrake, L A
245 0 0 _aPharmacokinetics of doxepin in subjects with pruritic atopic dermatitis.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cAug 1999
300 _a209-14 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Topical
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aAntipruritics
_xadministration & dosage
650 0 4 _aDermatitis, Atopic
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDoxepin
_xadministration & dosage
650 0 4 _aDrug Combinations
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOintments
650 0 4 _aTriamcinolone Acetonide
_xadministration & dosage
700 1 _aCohen, L
700 1 _aGillies, R
700 1 _aFlood, J G
700 1 _aRiordan, A T
700 1 _aPhillips, S B
700 1 _aStiller, M J
773 0 _tJournal of the American Academy of Dermatology
_gvol. 41
_gno. 2 Pt 1
_gp. 209-14
856 4 0 _uhttps://doi.org/10.1016/s0190-9622(99)70051-4
_zAvailable from publisher's website
999 _c10384828
_d10384828